Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orthofix Medical Inc.OFIX · Entity 1975 | Director | June 08, 2020 | June 10, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orthofix Medical Inc.
Report date June 08, 2020 · Filed June 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 164,122 |
Reported balance
After 2020-06-08 transaction · row 1
1 source rowRow 1 · 2020-06-08 · Grant · Acquired 8,520 · Balance 164,122 F1: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 8, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 8, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2020 Filed Jun 10, 2020 22:09 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 8,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035666 · doc4.xml · nonDerivative · entry 1 MATRICARIA RONALD A · CIK 0001221872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,122 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 8, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 11:08 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | PurchaseCommon Stock | 20,000 | $24.25 | $485,000.00 |
DisclosureSEC source: 0001209191-20-019880 · doc4.xml · nonDerivative · entry 1 MATRICARIA RONALD A · CIK 0001221872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,939 Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 21:10 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | PurchaseCommon Stock | 100 | $42.30 | $4,229.50 |
DisclosureSEC source: 0001209191-19-054868 · doc4.xml · nonDerivative · entry 3 MATRICARIA RONALD A · CIK 0001221872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,100 Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 21:10 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | PurchaseCommon Stock | 200 | $42.28 | $8,455.00 |
DisclosureSEC source: 0001209191-19-054868 · doc4.xml · nonDerivative · entry 2 MATRICARIA RONALD A · CIK 0001221872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,000 Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 21:10 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | PurchaseCommon Stock | 19,700 | $42.27 | $832,620.50 |
DisclosureSEC source: 0001209191-19-054868 · doc4.xml · nonDerivative · entry 1 MATRICARIA RONALD A · CIK 0001221872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,800 Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 21:59 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 6,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036914 · doc4.xml · nonDerivative · entry 1 MATRICARIA RONALD A · CIK 0001221872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,100 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 11, 2019. Read SEC document |
| July 17, 2018 Filed Jul 17, 2018 22:56 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 5,274 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042908 · doc4.xml · nonDerivative · entry 1 MATRICARIA RONALD A · CIK 0001221872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,887 F1 · shares: Deferred Stock Unit award granted on July 2, 2018, subject to shareholder approval, which was obtained on July 17, 2018, and is subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These awards vest in full on July 2, 2019. Read SEC document |
| May 03, 2018 Filed May 7, 2018 12:50 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | PurchaseCommon Stock | 10,000 | $51.97 | $519,724.00 |
DisclosureSEC source: 0001209191-18-028212 · doc4.xml · nonDerivative · entry 1 MATRICARIA RONALD A · CIK 0001221872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,613 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $51.73 to $52.00, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 21:53 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 6,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-044647 · doc4.xml · nonDerivative · entry 1 MATRICARIA RONALD A · CIK 0001221872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,394 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These awards vest in full on July 3, 2018. Vested shares of common stock will be delivered to the reporting person within 45 days after termination of service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.